GC Wealth Management RIA LLC Takes Position in Astera Labs, Inc. $ALAB

Key Points

• GC Wealth Management RIA LLC has purchased 3,518 shares of Astera Labs, Inc. for approximately $318,000, marking a new position in the company.
• A number of institutional investors have also increased their stakes in Astera Labs, collectively owning 60.47% of the company's stock.
• Astera Labs reported a quarterly earnings per share of $0.44, exceeding estimates, and projected guidance for Q3 2025 of $0.380-0.390 EPS.

GC Wealth Management RIA LLC purchased a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB - Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 3,518 shares of the company's stock, valued at approximately $318,000.

A number of other large investors have also added to or reduced their stakes in ALAB. Oliver Lagore Vanvalin Investment Group acquired a new stake in Astera Labs during the second quarter worth approximately $29,000. Sound Income Strategies LLC grew its position in Astera Labs by 34.7% during the first quarter. Sound Income Strategies LLC now owns 792 shares of the company's stock worth $47,000 after buying an additional 204 shares in the last quarter. GAMMA Investing LLC lifted its stake in Astera Labs by 55.7% during the first quarter. GAMMA Investing LLC now owns 794 shares of the company's stock worth $47,000 after purchasing an additional 284 shares during the last quarter. Harbour Investments Inc. lifted its stake in Astera Labs by 351.7% during the first quarter. Harbour Investments Inc. now owns 795 shares of the company's stock worth $47,000 after purchasing an additional 619 shares during the last quarter. Finally, Migdal Insurance & Financial Holdings Ltd. bought a new stake in Astera Labs during the first quarter worth $48,000. Institutional investors and hedge funds own 60.47% of the company's stock.

Astera Labs Trading Down 0.7%

Shares of ALAB opened at $194.50 on Thursday. The company has a market capitalization of $32.33 billion, a PE ratio of 347.32, a PEG ratio of 4.97 and a beta of 1.43. Astera Labs, Inc. has a 12 month low of $47.13 and a 12 month high of $262.90. The stock's 50-day moving average price is $186.50 and its two-hundred day moving average price is $117.29.

Astera Labs (NASDAQ:ALAB - Get Free Report) last announced its earnings results on Tuesday, August 5th. The company reported $0.44 EPS for the quarter, topping the consensus estimate of $0.33 by $0.11. The firm had revenue of $191.93 million for the quarter, compared to the consensus estimate of $172.46 million. Astera Labs had a return on equity of 9.53% and a net margin of 16.54%.The business's quarterly revenue was up 149.5% compared to the same quarter last year. During the same period in the previous year, the business earned $0.13 EPS. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. Equities research analysts predict that Astera Labs, Inc. will post 0.34 EPS for the current fiscal year.

Insider Buying and Selling

In other Astera Labs news, COO Sanjay Gajendra sold 280,000 shares of Astera Labs stock in a transaction dated Thursday, August 7th. The stock was sold at an average price of $170.02, for a total transaction of $47,605,600.00. Following the transaction, the chief operating officer directly owned 5,525,545 shares of the company's stock, valued at approximately $939,453,160.90. The trade was a 4.82% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Jitendra Mohan sold 152,517 shares of Astera Labs stock in a transaction dated Thursday, August 7th. The stock was sold at an average price of $170.33, for a total value of $25,978,220.61. Following the transaction, the chief executive officer directly owned 450,001 shares in the company, valued at $76,648,670.33. The trade was a 25.31% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 1,482,036 shares of company stock valued at $230,685,952 over the last 90 days. 12.50% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on ALAB shares. Morgan Stanley upped their target price on Astera Labs from $155.00 to $200.00 and gave the stock an "overweight" rating in a research note on Friday, August 29th. Deutsche Bank Aktiengesellschaft upped their target price on Astera Labs from $160.00 to $200.00 and gave the stock a "buy" rating in a research note on Tuesday, September 2nd. Cowen started coverage on Astera Labs in a research note on Tuesday. They set a "hold" rating for the company. CICC Research started coverage on Astera Labs in a research note on Friday, August 29th. They set an "outperform" rating and a $190.00 target price for the company. Finally, Needham & Company LLC upped their target price on Astera Labs from $100.00 to $170.00 and gave the stock a "buy" rating in a research note on Wednesday, August 6th. One research analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $155.71.

Astera Labs Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.